SAB Biotherapeutics Net Profit Margin Growth & History (SABS)
SAB Biotherapeutics's net profit margin was −2,579.03% for fiscal 2024.
View full SAB Biotherapeutics company overviewSAB Biotherapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −2,579.03% | −694.53 pp |
| 2023 | 2023-12-31 | −1,884.50% | −1806.10 pp |
| 2022 | 2022-12-31 | −78.40% | −50.24 pp |
| 2021 | 2021-12-31 | −28.16% | −64.58 pp |
| 2020 | 2020-12-31 | 36.42% | — |
SAB Biotherapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −9,934.52% | −2440.77 pp |
| Q2 2024 | 2024-06-30 | −2,787.69% | +5258.43 pp |
| Q1 2024 | 2024-03-31 | −532.06% | +733.43 pp |
| Q4 2023 | 2023-12-31 | −7,493.75% | −7129.33 pp |
| Q3 2023 | 2023-09-30 | −402.59% | −205.47 pp |
| Q2 2023 | 2023-06-30 | −8,046.13% | −7970.92 pp |
| Q1 2023 | 2023-03-31 | −1,265.50% | −1273.85 pp |
| Q4 2022 | 2022-12-31 | −364.42% | −259.96 pp |
| Q3 2022 | 2022-09-30 | −197.12% | −169.46 pp |
| Q2 2022 | 2022-06-30 | −75.21% | −59.05 pp |
| Q1 2022 | 2022-03-31 | 8.35% | +0.02 pp |
| Q4 2021 | 2021-12-31 | −104.46% | — |
| Q3 2021 | 2021-09-30 | −27.66% | — |
| Q2 2021 | 2021-06-30 | −16.15% | — |
| Q1 2021 | 2021-03-31 | 8.33% | — |
SAB Biotherapeutics net profit margin trends
Between the periods ended 2020-12-31 and 2024-12-31, SAB Biotherapeutics's net profit margin decreased from 36.42% to −2,579.03%, a change of −2615.45 percentage points. The latest reported quarter, Q4 2024, shows −9,934.52%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SAB Biotherapeutics source filings ↗